Gregory P. Kalemkerian

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Charles M. Rudin, Mark M. Awad, Alejandro Navarro et al. · Journal of Clinical Oncology · 2020 · 759 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

Feng‐Ming Kong, Randall K. Ten Haken, Matthew J. Schipper et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 499 citations

Medicine, Oncology, Radiation Oncology +16

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

Gregory P. Kalemkerian, Navneet Narula, Erin B. Kennedy et al. · Journal of Clinical Oncology · 2018 · 488 citations

Medicine, Oncology, Pathology +17

Small Cell Lung Cancer

Gregory P. Kalemkerian, Wallace Akerley, Robert J. Downey et al. · Journal of the National Comprehensive Cancer Network · 2013 · 455 citations · Full text

Medicine, Oncology, Pathology +14

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

Manisha H. Shah, Whitney Goldner, Þorvarður R. Hálfdánarson et al. · Journal of the National Comprehensive Cancer Network · 2018 · 391 citations · Full text

Medicine, Oncology, Surgery +17